Pennsylvania researchers have discovered that a sizable percentage of patients potentially at risk for cancer would turn down testing to uncover genes linked to the disease. While their study named cost as the most likely reason, a number of other factors could influence individuals to nix the tests.
View the original article here: Patients Nix Genetic Tests Due to Cost: Study
 |
Infographics | More... |
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
Viewpoint: Debunking organic food myths again… and again 
25 years of GMO crops: Economic, environmental and human health benefits 
Marrying your cousin? There may be evolutionary benefits 
Viewpoint: Should you be concerned when you read that a chemical in your food has been linked to cancer? Here’s an epidemiologist’s checklist to detect over-hyped scares 
Viewpoint: The organic food industry is a $180 billion marketing fraud 
KFC developing world’s first bioprinted chicken nuggets for planned rollout in Russia in fall 2020 
How Wegovy and Ozempic could transform our food systems 
Viewpoint: By engineering block on Vitamin A enhanced Golden Rice, Greenpeace ‘puts the whole environmental movement into disrepute’ 
Why humans have larger penises and smaller testicles than other great apes 
